 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper129th MAINE LEGISLATURE
FIRST REGULAR SESSION-2019
Legislative Document No. 1072
H.P. 795 House of  Representatives, March 5, 2019
An Act  To Promote Workforce Education  on Alzheimer's Disease  
and Dementia
Reference to the Committee on Health  Coverage, Insurance and Financial Services 
suggested and ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative CRAVEN of Lewiston.
Cosponsored by Senator GRATWICK of Penobscot and
Representatives: CLOUTIER of Lewiston, DOORE of Augusta, HICKMAN  of Winthrop,  
MADIGAN of Waterville, MEYER of Eliot, PERRY of Calais, SHEATS of Auburn, STOVER  
of Boothbay.

Page 1 - 129LR0771(01)-11Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  22 MRSA §1711-C, sub-§6, ¶T, as amended by PL 2017, c. 203, §3, is 
3further amended to read:
4T.  To a lay caregiver designated by an individual pursuant to section 1711-G; and
5Sec. 2.  22 MRSA §1711-C, sub-§6, ¶U, as enacted by PL 2017, c. 203, §4, is 
6amended to read:
7U.  To a panel coordinator of the maternal, fetal and infant mortality review panel 
8pursuant to section 261, subsection 4, paragraph B-1 for the purposes of reviewing 
9health care information of a deceased person and a mother of a child who died within 
10one year of birth, including fetal deaths after 28 weeks of gestation.  For purposes of 
11this paragraph, "panel coordinator" has the same meaning as in section 261, 
12subsection 1, paragraph E and "deceased person" has the same meaning as in section 
13261, subsection 1, paragraph B.; and
14Sec. 3.  22 MRSA §1711-C, sub-§6, ¶V is enacted to read:
15V.  To an authorized representative or family or household member of an individual 
16unless expressly prohibited by the individual when the health care practitioner is 
17providing a diagnosis of Alzheimer's disease or dementia.
18Sec. 4.  22 MRSA §§1725-A and 1725-B are enacted to read:
19§1725-A.  Alzheimer's disease and dementia service plans
20In addition to disclosing the diagnosis to the patient, a health care practitioner who 
21diagnoses Alzheimer's disease or dementia shall disclose the diagnosis to a family or 
22household member or to an authorized representative as defined in section 1711-C, 
23subsection 1, paragraph A pursuant to section 1711-C, subsection 6, paragraph V and 
24shall provide information to the family or household member or authorized representative 
25about care planning services, including assistance understanding the diagnosis, and 
26medical and nonmedical options for treatment, services and supports and information 
27about obtaining treatment, services and supports.
28§1725-B.  Alzheimer's disease and dementia hospital plans
29No later than January 1, 2023, a hospital shall develop and implement an operational 
30plan for the recognition and management of patients with Alzheimer's disease or 
31dementia within that hospital.  The plan must be developed in consultation with 
32organizations with expertise in the field of Alzheimer's disease and dementia.   The plan 
33must be kept on file in the hospital and made available to any person on request.
34Sec. 5.  22 MRSA §3473-A is enacted to read:
35§3473-A.  Alzheimer's disease and dementia training
36The department shall provide at least 4 hours of Alzheimer's disease and dementia 
37education and training to all employees or contract employees whose primary 
Page 2 - 129LR0771(01)-11responsibility is in adult protective services pursuant to this chapter at the beginning of 
2their employment.  The education and training must include:
31.  Symptoms.  Identification of psychiatric and behavioral symptoms of Alzheimer's 
4disease and dementia;
52.  Communication.  Information regarding communication issues, including how to 
6communicate effectively and in a respectful manner;
73.  Strategies.  Strategies and techniques for understanding and approaching 
8behavioral symptoms;
94.  Safety.  Information on how to address specific aspects of safety, including 
10wandering;
115.  Abuse and neglect.  Identification of types of neglect, abuse or exploitation of 
12persons with Alzheimer's disease and dementia; 
136.  Law enforcement.  When it is necessary to alert law enforcement of neglect, 
14abuse or exploitation by a family member, caretaker or facility;
157.  Self-neglect.  Identification of self-neglect by persons with Alzheimer's disease 
16and dementia who live independently; and
178.  Resources.  Resources to connect persons with Alzheimer's disease and dementia 
18to local resources, including professionals with expertise in care of persons with 
19Alzheimer's disease and dementia.
20Sec. 6.  32 MRSA §2213 is enacted to read:
21§2213.  Patients with cognitive impairments; continuing education
22By January 1, 2023, the board shall include, as part of required continuing education 
23for an individual licensed under this chapter, a 2-hour course on Alzheimer's disease and 
24dementia including diagnosis, behavioral symptoms, respectful and effective 
25communication, safety, signs of abuse and neglect and identifying signs of self-neglect by 
26persons living alone.  The course is not required for an individual licensed under this 
27chapter who does not serve adult populations as part of the individual's regular 
28employment.  The board shall adopt rules to implement this section.  Rules adopted 
29pursuant to this section are routine technical rules as defined in Title 5, chapter 375, 
30subchapter 2-A.
31Sec. 7.  32 MRSA §2594-E, sub-§6 is enacted to read:
326.  Patients with cognitive impairments; continuing education.  By January 1, 
332023, the board shall adopt rules jointly with the Board of Licensure in Medicine to 
34require, as part of continuing education requirements established pursuant to subsection 
355, paragraph I, the completion of a 2-hour course on Alzheimer's disease and dementia 
36including diagnosis, behavioral symptoms, respectful and effective communication, 
37safety, signs of abuse and neglect and identifying signs of self-neglect by persons living 
Page 3 - 129LR0771(01)-11alone.  Rules adopted pursuant to this subsection are routine technical rules as defined in 
2Title 5, chapter 375, subchapter 2-A.
3Sec. 8.  32 MRSA §2600-D is enacted to read:
4§2600-D.  Patients with cognitive impairments; continuing education 
5By January 1, 2023, the board shall include, as part of required continuing education 
6for an individual licensed under this chapter, a 2-hour course on Alzheimer's disease and 
7dementia including diagnosis, behavioral symptoms, respectful and effective 
8communication, safety, signs of abuse and neglect and identifying signs of self-neglect by 
9persons living alone.  The course is not required for an individual licensed under this 
10chapter who does not serve adult populations as part of the individual's regular 
11employment.  The board shall adopt rules to implement this section.  Rules adopted 
12pursuant to this section are routine technical rules as defined in Title 5, chapter 375, 
13subchapter 2-A.
14Sec. 9.  32 MRSA §3270-E, sub-§6 is enacted to read:
156.  Patients with cognitive impairments; continuing education.  By January 1, 
162023, the board shall adopt rules jointly with the Board of Osteopathic Licensure to 
17require, as part of continuing education requirements established pursuant to subsection 
185, paragraph I, the completion of a 2-hour course on Alzheimer's disease and dementia 
19including diagnosis, behavioral symptoms, respectful and effective communication, 
20safety, signs of abuse and neglect and identifying signs of self-neglect by persons living 
21alone.  Rules adopted pursuant to this subsection are routine technical rules as defined in 
22Title 5, chapter 375, subchapter 2-A.
23Sec. 10.  32 MRSA §3300-G is enacted to read:
24§3300-G.  Patients with cognitive impairments; continuing education
25By January 1, 2023, the board shall include, as part of required continuing education 
26for an individual licensed under this chapter, a 2-hour course on Alzheimer's disease and 
27dementia including diagnosis, behavioral symptoms, respectful and effective 
28communication, safety, signs of abuse and neglect and identifying signs of self-neglect by 
29persons living alone.  The course is not required for an individual licensed under this 
30chapter who does not serve adult populations as part of the individual's regular 
31employment.  The board shall adopt rules to implement this section.  Rules adopted 
32pursuant to this section are routine technical rules as defined in Title 5, chapter 375, 
33subchapter 2-A.
34Sec. 11.  Hospital plans.  A hospital developing and implementing a plan pursuant 
35to the Maine Revised Statutes, Title 22, section 1725-B shall consult with the Department 
36of Health and Human Services and statewide organizations with expertise in the field of 
37Alzheimer's disease and dementia and include relevant components from the federal 
38Department of Health and Human Services, Centers for Disease Control and Prevention, 
39Healthy Brain Initiative's publication, "State and Local Public Health Partnerships to 
40Address Dementia, The 2018-2023 Road Map," and any later federal plans and the 
Page 4 - 129LR0771(01)-11Department of Health and Human Services' State Plan for Alzheimer's Disease and 
2Related Dementias in Maine.
3SUMMARY
4This bill requires health care practitioners to disclose a diagnosis of Alzheimer's 
5disease or dementia to an authorized representative or a family or household member 
6except for a person that is expressly prohibited by the individual diagnosed.  The health 
7care practitioner making the diagnosis must also provide information regarding care 
8planning services, including assistance understanding the diagnosis, and medical and 
9nonmedical options for treatment, services and supports and information on how to 
10access those options.
11The bill requires that by January 1, 2023 every hospital must have a policy regarding 
12the recognition and management of patients with Alzheimer's disease and dementia 
13within that hospital and have the policy on file.  The hospital must consult with the 
14Department of Health and Human Services and statewide organizations with expertise in 
15the field of Alzheimer's disease and dementia and include relevant portions of the federal 
16Department of Health and Human Services, Centers for Disease Control and Prevention 
17"Healthy Brain Initiative" publication and any succeeding plans and the state plan 
18regarding Alzheimer's disease and related dementias in Maine developed by the 
19Department of Health and Human Services. 
20The bill also requires continuing education requirements to be adopted by the Board 
21of Licensure in Medicine, the Board of Osteopathic Licensure and the State Board of 
22Nursing that relate to diagnosis, behavioral symptoms, respectful and effective 
23communication, safety, signs of abuse and neglect and identifying signs of self-neglect by 
24persons living alone with Alzheimer's or dementia.  It also requires physician assistants to 
25receive the same continuing education.
26The bill also requires the Department of Health and Human Services to provide 4 
27hours of education and training to all employees of adult protective services at the 
28beginning of employment.
